Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice
Author:
Ren Ping,Peng Lei,Fang Zhenhao,Suzuki Kazushi,Renauer Paul,Lin Qianqian,Bai Meizhu,Yang Luojia,Li Tongqing,Clark Paul,Klein Daryl,Chen Sidi
Abstract
AbstractThe Omicron variant (B.1.1.529) of SARS-CoV-2 rapidly becomes dominant globally. Its extensive mutations confer severe efficacy reduction to most of existing antibodies or vaccines. Here, we developed RAMIHM, a highly efficient strategy to generate fully human monoclonal antibodies (mAbs), directly applied it with Omicron-mRNA immunization, and isolated three potent and specific clones against Omicron. Rapid mRNA immunization elicited strong anti-Omicron antibody response in humanized mice, along with broader anti-coronavirus activity. Customized single cell BCR sequencing mapped the clonal repertoires. Top-ranked clones collectively from peripheral blood, plasma B and memory B cell populations showed high rate of Omicron-specificity (93.3%) from RAMIHM-scBCRseq. Clone-screening identified three highly potent neutralizing antibodies that have low nanomolar affinity for Omicron RBD, and low ng/mL level IC50 in neutralization, more potent than majority of currently approved or authorized clinical RBD-targeting mAbs. These lead mAbs are fully human and ready for downstream IND-enabling and/or translational studies.
Publisher
Cold Spring Harbor Laboratory
Reference46 articles.
1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine 2. Omicron likely to weaken COVID vaccine protection 3. Cameroni, E. , Saliba, C. , Bowen, J.E. , Rosen, L.E. , Culap, K. , Pinto, D. , VanBlargan, L.A. , De Marco, A. , Zepeda, S.K. , Iulio, J.D. , et al. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 4. Cao, Y. , Wang, J. , Jian, F. , Xiao, T. , Song, W. , Yisimayi, A. , Huang, W. , Li, Q. , Wang, P. , An, R. , et al. (2021). Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 5. Carreno, J.M. , Alshammary, H. , Tcheou, J. , Singh, G. , Raskin, A. , Kawabata, H. , Sominsky, L. , Clark, J. , Adelsberg, D.C. , Bielak, D. , et al. (2021). Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|